Transcatheter arterial embolization for hemothorax caused by spinal fracture without arterial injury: a case report and review of the literature

Autor: Naoki Matsunaga, Takuya Okada, Yuko Ono, Keigo Matsushiro, Koji Sasaki, Tomoyuki Gentsu, Eisuke Ueshima, Keitaro Sofue, Masato Yamaguchi, Koji Sugimoto, Takamichi Murakami

Publikováno v: Journal of Medical Case Reports, Vol 16, Iss 1, Pp 1-6 (2022)

Abstract Background Spinal fractures rarely cause hemothorax, and no treatment consensus has been reached. Conservative treatment is generally selected in cases without arterial injury, but there have been some reports of uncontrolled bleeding. Here

Externí odkaz: https://doaj.org/article/0cfc3c21c2ea42eb9eb7f32487ca778b

Venous Thromboembolism in Japanese Patients with Gynecologic Cancer

Autor: Takahito Suzuki MD, Shota Tsurimoto MD, Takayasu Tada MD, Ryo Yamamura MD, Hiromasa Katoh MD, Yoshihiro Noji MD, Masato Yamaguchi MD, Susumu Fujino MD

Publikováno v: Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)

Objective Gynecologic cancer, including cervical, endometrial, and ovarian cancer, comprises the fifth leading type of cancer and is an important malignant disease in women. Previous studies in Western countries have reported respective prevalence ra

Externí odkaz: https://doaj.org/article/936113fbb0364a23830daa05d88ef0e0

Venous Thromboembolism in Japanese Patients With Pancreatic Cancer

Autor: Takahito Suzuki MD, Reina Hori MD, Kazutaka Takeuchi MD, Ryo Yamamura MD, Hiromasa Katoh MD, Yoshihiro Noji MD, Masato Yamaguchi MD, Susumu Fujino MD

Publikováno v: Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)

Objective Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths in Japan. Previous studies from other countries have reported venous thromboembolism prevalence rates of 12 to 36% in patients with pancreatic canc

Externí odkaz: https://doaj.org/article/25f8261e73cf4b9ab093108c4deb20b8

Hokuriku-plus familial hypercholesterolaemia registry study: rationale and study design

Autor: Hiroshi Matsumoto, Akihiro Nomura, Hayato Tada, Hirofumi Okada, Atsushi Nohara, Masa-aki Kawashiri, Koji Maeno, Manabu Fujimoto, Shohei Yoshida, Masaya Shimojima, Toyonobu Tsuda, Mika Mori, Shin-ichiro Takashima, Takeshi Kato, Soichiro Usui, Kenji Sakata, Kenshi Hayashi, Noboru Fujino, Akihiro Inazu, Shizuko Takahara, Yasuhito Imai, Takao Matsubara, Kenji Miwa, Masanobu Namura, Hidenobu Terai, Taiji Yoshida, Tsutomu Araki, Masahiro Minamoto, Toru Aburao, Yuji Ito, Chiaki Nakanishi, Suguru Kawasaki, Yasuhiro Todo, Junji Koizumi, Yoshihito Kita, Hiroaki Shintaku, Akihiko Hodatsu, Hidekazu Ino, Toshinori Higashikata, Mutsuko Takata, Katsushi Misawa, Masato Yamaguchi, Yoshihiro Noji, Kazuo Osato, Tomohito Mabuchi, Taro Ichise, Bunji Kaku, Shoji Katsuda, Katsuharu Uchiyama, Kensuke Fujioka, Takuya Nakahashi, Tsuyoshi Nozue, Ichiro Michishita, Kazuo Usuda, Kanichi Otowa, Kazuyasu Okeie, Satoshi Hirota, Isao Aburadani, Keisuke Kurokawa, Osamu Takatori, Shunichiro Hondo, Hiroyuki Oda, Shigeo Takata, Hisayoshi Murai, Masaki Kinoshita, Hideo Nagai, Yoshiteru Sekiguchi, Satoru Sakagami, Wataru Omi, Chikara Fujita, Tatsuo Katsuki, Hiroshi Ootsuji, Atsushi Igarashi, Manabu Nakano, Seiichiro Okura, Yasuhito Mitamura, Naoki Sugimoto, Masakazu Yamamoto, Hironobu Akao, Kouji Kajinami, Masayuki Takamura

Publikováno v: BMJ Open, Vol 10, Iss 9 (2020)

Introduction Familial hypercholesterolaemia (FH) is an autosomal-dominant inherited genetic disease. It carries an extremely high cardiovascular risk associated with significantly elevated low-density lipoprotein (LDL) cholesterol. The diagnostic rat

Externí odkaz: https://doaj.org/article/917dd099aa3a44eba50203d24f5b2dba

Impact of renal function on mid-term outcomes in heart failure patients treated with tolvaptan

Autor: Kensuke Fujioka, Sumio Mizuno, Taro Ichise, Takao Matsui, Hiroaki Hirase, Masato Yamaguchi, Takahiko Aoyama, Masakazu Yamagishi, Noboru Fujino, Masa-aki Kawashiri, Kenshi Hayashi

Publikováno v: Therapeutic Advances in Cardiovascular Disease, Vol 13 (2019)

Background: Although tolvaptan, an electrolyte-free water diuretic for congestive heart failure (HF), is reported to have no effect on long-term mortality or HF-related morbidity, there may exist some subgroups of patients who may receive beneficial

Externí odkaz: https://doaj.org/article/0134b8f924314b3685ed9a97fb0f64a8